Teesside TV

Sunrise Sunset
°C
Today
24/01/2022
°C
Tonight
24/01/2022
°C
Tomorrow
25/01/2022
°C
Saturday
26/01/2022
°C
Sunday
27/01/2022
°C
Monday
28/01/2022
°C

VACCINE & PREGNANCY: Study begins to determine how the vaccine impacts pregnancy

VACCINE & PREGNANCY: Study begins to determine how the vaccine impacts pregnancy

Published 17-05-21

 

A trial to determine the impact of taking the coronavirus vaccine during pregnancy has begun in Newcastle.

11 sites in the UK are taking part in the trial, including the Royal Victoria Infirmary in Newcastle. The plan is to inject 235 pregnant people with the Pfizer-BioNtech vaccine to better understand any safety concerns and asses how effective it is.

In April, guidance from the Joint Committee on Vaccination and Immunisation recommended that pregnant women could be offered approved Covid-19 vaccines at the same time as the rest of the UK population, based on their age and clinical risk group.

Over in the United States, results were collected after over 100,000 pregnant women were vaccinated with various jabs, some of which were the Pfizer-BioNtech dose. No safety concerns were raised.

The study is currently welcoming applicants who are aged over 18 and are 24-34 weeks into a single, uncomplicated pregnancy. Participants will be identified via health care professionals including midwives at the hospital sites involved.

All volunteers will need to visit their site for four planned visits before their baby is born and then two more follow up appointments after the baby is born.

The trial will also be taking place in Southampton. Dr Chrissie Jones, associate professor in paediatric infectious diseases at the University of Southampton, and chief investigator for the study said: “While we have a large amount of real-world data which tells us that it’s safe for pregnant women to receive approved Covid-19 vaccines, the data gathered from a controlled research study like this is important because it will give us more information about the vaccine immune response in pregnant women, including the transfer of maternal antibodies to infants.

“All women taking part in the study will receive two doses of the approved Pfizer/BioNTech vaccine, as well as additional monitoring and support from their local research team.”

 

 

 


Watch Live


Watch the channel on TV

7

Freeview

195

Sky

159

Virgin Media